RedHill Biopharma's antibiotic succeeds in late-stage study

Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients with a type of bacterial infection that affects the stomach and small intestine.

from Reuters: Health News https://ift.tt/2rjXBUS
via IFTTT